Skip to content

Price / book at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
158.4×+51.5×
Biogen logo
BiogenBIIB
1.4×+0.3×
Alkermes logo
AlkermesALKS
3.4×-0.2×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×
TG Therapeutics logo
TG TherapeuticsTGTX
9.1×-17.0×

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s price / book?
Praxis Precision Medicines, Inc. (PRAX) reported price / book of 6.4× in Q1 2026.
How has Praxis Precision Medicines, Inc.'s price / book changed year-over-year?
Praxis Precision Medicines, Inc.'s price / book increased by 266.1% year-over-year, from 1.7× to 6.4×.
What is the long-term trend for Praxis Precision Medicines, Inc.'s price / book?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s price / book has grown at a -0.5% compound annual growth rate (CAGR), from 8.6× to 8.4×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.